CEO Mike Doustdar informed Bloomberg that Novo Nordisk’s Athlone site will begin manufacturing Wegovy exclusively for markets outside the United States.
Back
CEO Mike Doustdar informed Bloomberg that Novo Nordisk’s Athlone site will begin manufacturing Wegovy exclusively for markets outside the United States.